BANK VONTOBEL/CALL/STRYKER CORP./340/0.1/20.12.24 Stock

Warrant

DE000VD36EP9

Real-time Bid/Ask 10:22:15 2024-07-11 am EDT
2.21 EUR / 2.24 EUR +8.54% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./340/0.1/20.12.24
Current month-13.87%
1 month-29.79%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 2.14 +4.39%
24-07-10 2.05 +2.50%
24-07-09 2 -5.21%
24-07-08 2.11 +5.50%
24-07-05 2 +5.26%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 02:28 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD36EP
ISINDE000VD36EP9
Date issued 2024-04-15
Strike 340 $
Maturity 2024-12-20 (162 Days)
Parity 10 : 1
Emission price 3.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.3
Lowest since issue 1.79
Spread 0.11
Spread %4.89%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
337.3 USD
Average target price
372.4 USD
Spread / Average Target
+10.40%
Consensus